Primary care at the forefront of colorectal cancer screening

Size: px
Start display at page:

Download "Primary care at the forefront of colorectal cancer screening"

Transcription

1 Primary care at the forefront of colorectal cancer screening Presentation by Bohumil Seifert Department of General Practice, 1st Faculy of Medicine, Charles University in Prague 04/05/2012

2 Introduction Prague Institute of General Practice, Prague Training practice 2 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

3 Special interest in colorectal cancer screning A member of a Foundation which initiated colorectal cancer screening in the Czech Republic in 2000 Representative of GPs in Czech National Colorectal Cancer Screening Committee Education for GPs and public on CRC screening Research on - the role of primary care physicians in screening - attitudes toward screening in target population - FOBT methods 3 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

4 Characteristics of the medicine in the 3rd millenium Key issue: Non-communicable diseases Fascinating technology development Succeses in diagnostics and treatment and improvement of prognosis of serious diseases Successes and expectations push medicine towards prevention towards pro-active inteventions in asymptomatic people 4 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

5 Prevention and screening Consequencies: Ethics (nature of patient doctor relation) Safety Costs Capacity 5 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

6 Colorectal cancer is the most preventable visceral form of cancer Stage of diagnosis matters! Early diagnostics helps to increase 5-year survival: Duke s A (90%) v. stage with distant metastases ( 10%) Colorectal cancer is preventable before exists. Identification and excision of risk polyps About half of polyps/cancers bleed and blood can be detected by simple test. Colonoscopy is a method with high diagnostic and curable capacity 6 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

7 Early diagnostics of colorectal cancer The principal method of identification of colorectal cancer stays symptomatic presentation to GPs who are source of referral to secondary care. 90% of colorectal cancers detected Importance of research on early diagnostics 7 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

8 Early diagnostics of colorectal cancer GP Competence Interdisciplinary cooperation Referral system Capacity Access to colonoscopy, waiting times Prioritization Research: -on sensitivity, specificity, PPV of symptoms -on markers (ifob, M2-PK, calprotectin stool test) 8 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

9 Role of primary care in prevention Primary prevention Secondary prevention: -screening programmes for high risk persons -screening programmes for average risk p. Early diagnosis in symptomatic Quality of care/tertiary prevention 9 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

10 CRC screening: Implications for General Practice The involvement of GPs varies in countries according to The involvement of GPs varies in countries according to chosen strategy: chosen strategy: Direct: performing FOBT (CR, SLO, GER) Direct: performing FOBT (CR, SLO, GER) Indirect: recruitment for colonoscopy screening (Pol) Indirect: recruitment for colonoscopy screening (Pol) Supportive: administrative, advices (UK) Supportive: administrative, advices (UK) The involvement of people Population The involvement based screening of people (central invitation UK) Organized screening (GP/patient activities,ge,czech) Opportunistic screening (Poland) Population based screening (central invitation UK) Organized screening (GP/patient activities,ge,czech) Opportunistic screening (Poland) Lionis C. Colorectal cancer screening and the challenging role of general practitioner/ family physician: an issue of quality, Quality in Primary Care 2007; 15: Seifert B., The role of primary care in colorectal cancer screening: The experience from the Czech Republic, Neoplasma, 2008; 55: Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

11 Benefits of primary care involvement in screening program complex approach to person personalised care additional value of preventive/screening programs (CV, GYN, MAM, CRC) cheaper 11 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

12 Burden of screening program in primary care Workload (up to 300 FOBT per year per practice) Organization issues Ethics Bad news 12 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

13 What matters the most in screening? If we put money in colorectal cancer screening what affects the most the outcomes? 1. Adherence rate? 2. Choice of primary test? 3. Quality/capacity of endoscopic services? 4. Program monitoring /data collection? 13 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

14 1. Adherence rate 14 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

15 Population based v. organized screening Programs using invitation system show higher adherence of target population Central invitiation is the only way how to get participation over 50%. Invitation via GP offices increases the adherence rate in 8% (UK) CZECH PROGRAM: letters administered by sick funds (different for all three programs) will invite people to GPs (gynaecologists, mamma centrum) since Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

16 1. Choice of primary test 16 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

17 European guidelines: FOBT Dietary restriction is not indicated for programmes using either guaiac-based or immunochemical tests Drug restriction is not recommended for population screening programmes using either guaiac-based or immunochemical test The ifobt is preferable over gfobt (higher participation, smaller number of stool samples needed, automated reading, greater sensitivity for detection of advanced adenomas, similar PPV)

18 Optimal FOBT Without diet restriction Simple (user friendly) quantitative sampling Easy logistics (POCT?) Automatic reading Cut off options with regards to - optimal sensitivity and specificity - safety, capacity and cost/benefit - risk groups (men, seniors, diabetics) Quantitative ifob tests 18 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

19 FOBT: Cut off optimalization CUT OFF high low Number of colonoscopies Sensitivity Specificity PPV Chen, 2007: Rossum, 2009: ng/ml faecal hemoglobin 75 ng/ml for the Netherland 200ng/ml where CS capacity is insuff. Recent Czech study shows, that suggested cut off 75ng/ml would mean FOBT positivity rate 12-16% compare to current 4% with gfobt. 19 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

20 4. Program monitoring/data collection? 20 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

21 Data collection Epidemiology: incidence prevalence mortality staging 5 years survival Quality of life Outcomes, Efficiency, Screening: FOBT PS colonoscopy S colonoscopy Follow up Diagnostics Treatment Costs, Capacity Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

22 Primary care data: Effect of measures for improvement centrally collected (hard) data/indicators: - FOBT adherence rate - FOBT positivity rate - GPs, gynaecologists involvement - regional differencies primary care collected data (experimentally) - waiting times for colonoscopies - compliance with colonoscopy in FOBT positives - feedback on endoscopic services/adherence to guidelines Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

23 Colorectal Cancer: Imperatives for primary care Do not miss a symptomatic cancer/refer in time! Identify high risk patients! Screen for colorectal cancer! 23 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

24 Thank you for attending, if you are interested in finding out more about UEG visit Like us on Facebook at Tweet us Presentation by Bohumil Seifert Department of General Practice, 1st Faculy of Medicine, Charles University in Prague 17/05/2012

GENERAL PRACTITIONERS IN THE 1ST LINE OF CANCER PREVENTION

GENERAL PRACTITIONERS IN THE 1ST LINE OF CANCER PREVENTION GENERAL PRACTITIONERS IN THE 1ST LINE OF CANCER PREVENTION Bohumil Seifert Dpt. Of General Practice 1st Faculty of Medicine Charles University in Prague May, 29, 2015 European Colorectal Cancer Days, Brno

More information

Practical challenges in establishing and running the Czech national colorectal cancer screening programme

Practical challenges in establishing and running the Czech national colorectal cancer screening programme Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha 1. lékařská fakulta Univerzity Karlovy Interní klinika Practical challenges in establishing and running the Czech national colorectal cancer

More information

Czech CRC screening program at the point of switch to the population based design

Czech CRC screening program at the point of switch to the population based design Military University Hospital First Medical Faculty of Charles University Department of Gastroenterology Czech CRC screening program at the point of switch to the population based design M. Zavoral, S.

More information

Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc.

Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc. Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc. European Digestive Cancer Days, Prague - 26. September 2017 QUANTITATIVE FIT

More information

INTERACTION WITH SCREENEES AND PATIENT ORGANIZATIONS

INTERACTION WITH SCREENEES AND PATIENT ORGANIZATIONS ESPCG European Society for Primary Care Gastroenterology INTERACTION WITH SCREENEES AND PATIENT ORGANIZATIONS Bohumil Seifert Dpt. Of General Practice 1st Faculty of Medicine Charles University in Prague

More information

Faecal Immunochemical Testing (FIT) for Screening and Symptomatic Patients

Faecal Immunochemical Testing (FIT) for Screening and Symptomatic Patients Faecal Immunochemical Testing (FIT) for Screening and Symptomatic Patients Caroline Addison NE BCSP Hub Director and Consultant Clinical Scientist What is FIT Type of Faecal Occult Blood test Designed

More information

Bowel cancer screening and prevention

Bowel cancer screening and prevention Bowel cancer screening and prevention Cancer Incidence and Mortality Victoria 2012 Number 6000 5000 4000 3000 2000 Incidences = 29,387 Mortality = 10,780 Incidence Mortality 1000 0 Prostate Breast Bowel

More information

The choice of methods for Colorectal Cancer Screening; The Dutch experience

The choice of methods for Colorectal Cancer Screening; The Dutch experience The choice of methods for Colorectal Cancer Screening; The Dutch experience Monique van Leerdam, Gastroenterologist, NKI-AVL, Amsterdam The Netherlands Colorectal cancer CRC 2 nd cause of cancer related

More information

Implementing of Population-based FOBT Screening

Implementing of Population-based FOBT Screening Implementing of Population-based FOBT Screening gfobt to FIT Experience from England Prof Stephen P. Halloran Guaiac FOBt Haem 2H 2 O 2 = 2H 2 0 + O 2 Oxidised guaiaconic acid is blue Biennial Bowel Cancer

More information

Dr Alasdair Patrick. Dr Nagham Al-Mozany. 9:45-10:10 Where Are We Up To With Bowel Cancer Screening?

Dr Alasdair Patrick. Dr Nagham Al-Mozany. 9:45-10:10 Where Are We Up To With Bowel Cancer Screening? Dr Alasdair Patrick Gastroenterologist and General Physician Middlemore Hospital Auckland Dr Nagham Al-Mozany Colorectal Surgeon Auckland City Hospital Clinical Senior Lecturer University of Auckland 9:45-10:10

More information

COLORECTAL CANCER: A CHALLENGE FOR HEALTHY LIFESTYLE, SCREENING AND PROPER CARE

COLORECTAL CANCER: A CHALLENGE FOR HEALTHY LIFESTYLE, SCREENING AND PROPER CARE COLORECTAL CANCER: A CHALLENGE FOR HEALTHY LIFESTYLE, SCREENING AND PROPER CARE Brno, 29 May 2015: For the fourth time in a row, the second largest city of the Czech Republic will host the European Colorectal

More information

FECAL OCCULT BLOOD TEST (FOBT) Common Guaiac versus Immunochemical Test

FECAL OCCULT BLOOD TEST (FOBT) Common Guaiac versus Immunochemical Test FECAL OCCULT BLOOD TEST (FOBT) Common Guaiac versus Immunochemical Test LIMBACH-LABORATORY H E I D E L B E R G H J Roth H Schmidt-Gayk Estimated incidence of cancer in Europe and European Union, 2006 Limbach

More information

Measuring performance and quality indicators of CRC screening

Measuring performance and quality indicators of CRC screening Measuring performance and quality indicators of CRC screening Ondřej MÁJEK Institute of Biostatistics and Analyses, Masaryk University Institute of Biostatistics and Analyses, Masaryk University, Brno

More information

FIT Overview. Objectives 6/23/2014

FIT Overview. Objectives 6/23/2014 ADDS 2014: Plenary 2 FIT Update Clarence Wong, MD FRCPC Associate Professor of Medicine, University of Alberta Provincial Medical Lead, Alberta Colorectal Cancer Screening Program 1 Objectives After this

More information

Screening for GI Cancer Past Present and Future. Prof. Bob Steele University of Dundee

Screening for GI Cancer Past Present and Future. Prof. Bob Steele University of Dundee Screening for GI Cancer Past Present and Future Prof. Bob Steele University of Dundee Worldwide Cancer Incidence Rates UK Cancer Incidence Rates Screening The detection of disease in asymptomatic subjects

More information

Colorectal cancer screening

Colorectal cancer screening 26 Colorectal cancer screening BETHAN GRAF AND JOHN MARTIN Colorectal cancer is theoretically a preventable disease and is ideally suited to a population screening programme, as there is a long premalignant

More information

Challenges for Colorectal Cancer Screening

Challenges for Colorectal Cancer Screening Challenges for Colorectal Cancer Screening a Biomarker with No Standards! Prof. Emeritus Stephen P. Halloran University of Surrey W. Europe Top 20 Cancers Men Incidence & Mortality (2012) Women World -

More information

Citation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy

Citation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy UvA-DARE (Digital Academic Repository) Population screening for colorectal cancer by colonoscopy de Wijkerslooth, T.R. Link to publication Citation for published version (APA): Wijkerslooth de Weerdesteyn,

More information

Faecal testing in colorectal cancer screening: State of the Art. Prof Stephen P. Halloran

Faecal testing in colorectal cancer screening: State of the Art. Prof Stephen P. Halloran Faecal testing in colorectal cancer screening: State of the Art Prof Stephen P. Halloran Faecal Immunochemical Test (FIT) gfobt Globin (Human) Haem Guaiac test gfobt Study Cohort 10,011 L Hol et al Gut

More information

Reflections on the EUnetHTA CRC screening full Core Model pilot 1

Reflections on the EUnetHTA CRC screening full Core Model pilot 1 Reflections on the EUnetHTA CRC screening full Core Model pilot 1 EUnetHTA Medical Technology HTA expert meeting Brussels October 16th 2015 Karsten Berndt, Economist & Epidemiologist, EDMA HTA Task Force

More information

Bowel Cancer Screening Exploiting science brings better medicine

Bowel Cancer Screening Exploiting science brings better medicine Camberley & District Bowel Cancer Screening Exploiting science brings better medicine Prof Stephen P. Halloran World - All Cancers Men Incidence & Mortality (2012) Women Incidence Mortality GLOBOCAN 2012

More information

Increasing Colorectal Cancer Screening in Wyoming. Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program

Increasing Colorectal Cancer Screening in Wyoming. Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program Increasing Colorectal Cancer Screening in Wyoming Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program Overview What is colorectal cancer? What are risk factors for

More information

Optimizing implementation of fecal immunochemical testing in Ontario: A randomized controlled trial

Optimizing implementation of fecal immunochemical testing in Ontario: A randomized controlled trial Optimizing implementation of fecal immunochemical testing in Ontario: A randomized controlled trial J. Tinmouth, N.N. Baxter, L.F. Paszat, E. Randell, M. Serenity, R. Sutradhar, L. Rabeneck Conflicts of

More information

Global colorectal cancer screening appropriate or practical? Graeme P Young, Flinders University WCC, Melbourne

Global colorectal cancer screening appropriate or practical? Graeme P Young, Flinders University WCC, Melbourne Global colorectal cancer screening appropriate or practical? Graeme P Young, Flinders University. 2014 WCC, Melbourne Outline WHO criteria to justify screening Appropriateness: Global variation in incidence

More information

Be it Resolved that FIT is the Best Way to Screen for Colorectal Cancer DEBATE

Be it Resolved that FIT is the Best Way to Screen for Colorectal Cancer DEBATE Be it Resolved that FIT is the Best Way to Screen for Colorectal Cancer DEBATE DEBATE Presenters PRESENTATION MODERATOR Dr. Praveen Bansal -MD, CCFP FCFP Regional Primary Care Lead, Integrated Cancer Screening,

More information

Prof Stephen P. Halloran. Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT

Prof Stephen P. Halloran. Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT Prof Stephen P. Halloran Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT World Top 20 Cancers Men Incidence & Mortality (2012) Women World Colorectal Cancer 3 rd commonest cancer 4

More information

Implementation of Faecal Immunochemical Testing as the screening test for Bowel Screening. Programme in Wales

Implementation of Faecal Immunochemical Testing as the screening test for Bowel Screening. Programme in Wales Immunochemical Testing as the screening test for Bowel Screening. Programme in Wales Information to Public Health Wales Board prior to introduction Author: Dr Sharon Hillier, Acting Director Screening

More information

Risk assessment tools for the symptomatic population Graham Radford-Smith Department of Gastroenterology and Hepatology Royal Brisbane and Women s

Risk assessment tools for the symptomatic population Graham Radford-Smith Department of Gastroenterology and Hepatology Royal Brisbane and Women s Risk assessment tools for the symptomatic population Graham Radford-Smith Department of Gastroenterology and Hepatology Royal Brisbane and Women s Hospital GI inflammation IBD Group QIMR Berghofer Medical

More information

EVALUATION OF QUANTITATIVE DETECTION OF FECAL HUMAN HAEMOGLOBIN FOR COLORECTAL CANCER SCREENING

EVALUATION OF QUANTITATIVE DETECTION OF FECAL HUMAN HAEMOGLOBIN FOR COLORECTAL CANCER SCREENING EVALUATION OF QUANTITATIVE DETECTION OF FECAL HUMAN HAEMOGLOBIN FOR COLORECTAL CANCER SCREENING Kocna P., Vaníčková Z., Kovářová J., Krechler T., Kohout P., Beneš Z., Granátová J. Institute of Clinical

More information

Colorectal Cancer Screening and Risk Assessment Workflow. Documentation Guide for Health Center NextGen Users

Colorectal Cancer Screening and Risk Assessment Workflow. Documentation Guide for Health Center NextGen Users Colorectal Cancer Screening and Risk Assessment Workflow Documentation Guide for Health Center NextGen Users Colorectal Cancer Screening and Risk Assessment Workflow and Documentation Guide for Health

More information

North West London Pathology. Faecal Occult Blood testing. Mrs Sophie Barnes FRCPath Consultant Clinical Scientist

North West London Pathology. Faecal Occult Blood testing. Mrs Sophie Barnes FRCPath Consultant Clinical Scientist Faecal Occult Blood testing Mrs Sophie Barnes FRCPath Consultant Clinical Scientist Learning objectives Background Guidelines for colorectal cancer detection Tests available to detect occult blood in faeces

More information

CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING

CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING This guideline is designed to assist practitioners by providing the framework for colorectal cancer (CRC) screening, and is not intended to replace

More information

Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests

Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests Results of a systematic review, Kaiser experience, and implications for the Canton of Vaud Kevin Selby, M.D. Kevin.Selby@hospvd.ch

More information

Achieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016

Achieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016 Achieving 80% by 2018: Working Together Can Get Us There Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016 1 Prostate 21% Lung & bronchus 14% Colon & rectum 8% Urinary bladder 7% Melanoma of skin

More information

COLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST

COLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST COLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST MATHEW.ESTEY@DYNALIFEDX.COM FACULTY /PRESENTER DISCLOSURE FACULTY: MATHEW ESTEY RELATIONSHIPS

More information

NHS Bowel Cancer Screening Programmes: Evaluation of pilot of Faecal Immunochemical Test : Final report.

NHS Bowel Cancer Screening Programmes: Evaluation of pilot of Faecal Immunochemical Test : Final report. NHS Bowel Cancer Screening Programmes: Evaluation of pilot of Faecal Immunochemical Test : Final report. Sue Moss, Christopher Mathews Centre for Cancer Prevention, Wolfson Institute, Queen Mary University

More information

CRC screening from the viewpoint of its clients and patients results of survey

CRC screening from the viewpoint of its clients and patients results of survey 4th European Colorectal Cancer Days, 29 30 May 2015 Brno, Czech Republic. CRC screening from the viewpoint of its clients and patients results of survey Kroupa Radek, Ondráčková Monika University Hospital

More information

Colorectal cancer screening in England

Colorectal cancer screening in England Colorectal cancer screening in England critical analysis Prof Stephen P. Halloran Participation Rate 57% All Screens (1.9% +ve) 52% Prevalent 1 st Screen (age 60 years) 36% Prevalent Screen (2.2% +ve)

More information

Bowel Cancer Prevention and Screening. Harriet Wynne, Cancer Council Victoria

Bowel Cancer Prevention and Screening. Harriet Wynne, Cancer Council Victoria Bowel Cancer Prevention and Screening Harriet Wynne, Cancer Council Victoria New cases and deaths for the Victoria population in 2013 Thursfield V, et al. Cancer in Victoria: Statistics & trends 2013.

More information

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC 10:45 11:45 am Guide to Colorectal Cancer Screening SPEAKER Howard Manten M.D. Presenter Disclosure Information The following relationships exist related to this presentation: Howard Manten MD: No financial

More information

Monitoring of equity in access to CRC screening and CRC care: two sides of the same coin

Monitoring of equity in access to CRC screening and CRC care: two sides of the same coin Monitoring of equity in access to CRC screening and CRC care: two sides of the same coin Ondřej MÁJEK Institute of Biostatistics and Analyses, Masaryk University Institute of Biostatistics and Analyses,

More information

Debate: General surveillance/screening for colon cancer in a resource constrained environment is imperative

Debate: General surveillance/screening for colon cancer in a resource constrained environment is imperative Debate: General surveillance/screening for colon cancer in a resource constrained environment is imperative Dr. Meryl Oyomno Department of surgery, University of Pretoria INTRODUCTION Screening is the

More information

An Update on the Bowel Cancer Screening Programme. Natasha Djedovic, London Hub Director 17 th September 2018

An Update on the Bowel Cancer Screening Programme. Natasha Djedovic, London Hub Director 17 th September 2018 An Update on the Bowel Cancer Screening Programme Natasha Djedovic, London Hub Director 17 th September 2018 NHS Bowel Cancer Screening Programme 2006: 60-69 yr old men & women offered guaiac Faecal Occult

More information

Performance of Colorectal cancer screening in the European Union Member States Data from the second European screening report

Performance of Colorectal cancer screening in the European Union Member States Data from the second European screening report Performance of Colorectal cancer screening in the European Union Member States Data from the second European screening report 1 Basu P 2, Anttila A 3, Ponti A 1, Tomatis M 1, Vale DB 4, Ronco G 1, Soerjomataram

More information

ADENOMA SURVEILLANCE BCSP Guidance Note No 1 Version 1 September 2009

ADENOMA SURVEILLANCE BCSP Guidance Note No 1 Version 1 September 2009 ADENOMA SURVEILLANCE BCSP Guidance Note No 1 Version 1 September 2009 Published by: NHS Cancer Screening Programmes Fulwood House Old Fulwood Road Sheffield S10 3TH Tel: 0114 271 1060 Fax: 0114 271 1089

More information

Colorectal Cancer Screening. Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital

Colorectal Cancer Screening. Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital Colorectal Cancer Screening Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital March, 2018 CRC Epidemiology 4th most common malignancy in US (136,000 cases/yr) 2nd

More information

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background Colorectal Cancer Screening Payam Afshar, MS, MD Kaiser Permanente, San Diego Objectives Colorectal cancer background Colorectal cancer screening populations Colorectal cancer screening modalities Colonoscopy

More information

Programme September 2017 Prague, Czech Republic

Programme September 2017 Prague, Czech Republic Programme 25 27 September 2017 Prague, Czech Republic Programme committee chairs Ladislav Dušek (Czech Republic) Director of the Institute of Health Information And Statistics of the Czech Republic Monday,

More information

Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests

Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests O R I G I N A L A R T I C L E Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests L.G.M. van Rossum 1*, A.F. van Rijn 2, I.P. van Munster 3, J.B.M.J. Jansen 1, P.

More information

EU Guidelines for quality assurance in organization, implementation and monitoring of colorectal cancer screening programme. Jožica Maučec Zakotnik

EU Guidelines for quality assurance in organization, implementation and monitoring of colorectal cancer screening programme. Jožica Maučec Zakotnik EU Guidelines for quality assurance in organization, implementation and monitoring of colorectal cancer screening programme Jožica Maučec Zakotnik EU guidelines Luxembourg 2010 EU guidelines - chapters

More information

Financial Disclosers

Financial Disclosers Slide 1 Colorectal Cancer Screening Jason Hemming, MD NESGNA November 15, 2014 Slide 2 Bio Slide 3 Financial Disclosers I have no actual or potential conflict of interest relation to this presentation

More information

Colorectal Cancer Screening State of the art in Eastern Europe. Mārcis Leja Prague, September 27, 2017

Colorectal Cancer Screening State of the art in Eastern Europe. Mārcis Leja Prague, September 27, 2017 Colorectal Cancer Screening State of the art in Eastern Europe Mārcis Leja Prague, September 27, 2017 The borders of Eastern Europe? EU Urals Bering Sea 2 3 4 CRC screening programs in EU in 2016 Cancer

More information

Give Yourself the All Clear Colorectal Cancer Prevention and Screening: What YOU Need to Know

Give Yourself the All Clear Colorectal Cancer Prevention and Screening: What YOU Need to Know Give Yourself the All Clear Colorectal Cancer Prevention and Screening: What YOU Need to Know Colorectal cancer kills through embarrassment We know that colorectal cancer can still be a bit of a taboo

More information

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

Prevention of Bowel Cancer: which patients do I send for colonoscopy? Prevention of Bowel Cancer: which patients do I send for colonoscopy? Dr Chris Groves Consultant Gastroenterologist and Honorary Senior Lecturer St George s Hospital and Medical School Director, SW London

More information

The Dutch bowel cancer screening program Relevant lessions for Ontario

The Dutch bowel cancer screening program Relevant lessions for Ontario The Dutch bowel cancer screening program Relevant lessions for Ontario Ernst J Kuipers Erasmus MC University Medical Center Rotterdam - The Netherlands 1 Ismar Boas (1858 1938) Colorectal cancer screening

More information

Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West

Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West The South West Cancer Alliances have been awarded transformation funding to provide access to

More information

Engaging Primary Care in bowel screening

Engaging Primary Care in bowel screening Engaging Primary Care in bowel screening GP good practice guide for Wales December 2018 Together we will beat cancer Contents Background 3 The FIT screening pathway in Wales 4 The role of GP practices

More information

Setting The setting was primary and secondary care. The economic study was carried out in Taiwan.

Setting The setting was primary and secondary care. The economic study was carried out in Taiwan. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries Wu G H, Wang Y W, Yen A M, Wong J M, Lai H C, Warwick J, Chen T H Record Status This

More information

On-going and planned colorectal cancer clinical outcome analyses

On-going and planned colorectal cancer clinical outcome analyses On-going and planned colorectal cancer clinical outcome analyses Eva Morris Cancer Research UK Bobby Moore Career Development Fellow National Cancer Data Repository Numerous routine health data sources

More information

Colorectal Cancer. Mark Chapman. MA MS FRCS EBSQ(coloproct) 21 st March 2018 Consultant Coloproctologist

Colorectal Cancer. Mark Chapman. MA MS FRCS EBSQ(coloproct) 21 st March 2018 Consultant Coloproctologist Colorectal Cancer Mark Chapman MA MS FRCS EBSQ(coloproct) 21 st March 2018 Consultant Coloproctologist Overview Epidemiology of colorectal cancer Adenoma carcinoma sequence Tumour diagnosis & staging Treatment

More information

ColonCancerCheck & Regional Updates. Cheryl Shoemaker RN, BScN, CON(C) March 19, 2014

ColonCancerCheck & Regional Updates. Cheryl Shoemaker RN, BScN, CON(C) March 19, 2014 ColonCancerCheck & Regional Updates Cheryl Shoemaker RN, BScN, CON(C) March 19, 2014 Colorectal Cancer Facts 3 rd most commonly diagnosed cancer 2nd leading cause of cancer death in men & 3 rd cancer death

More information

Bowel Cancer Screening

Bowel Cancer Screening Bowel Cancer Screening Dr John Hancock FRCP Consultant Gastroenterologist University Hospital of North Tees Outline Background Current bowel cancer screening programme Tees Screening Centre Future Flexi

More information

Emerging Interventions in Endoscopy. Margaret Vance Nurse Consultant in Gastroenterology St Mark s Hospital

Emerging Interventions in Endoscopy. Margaret Vance Nurse Consultant in Gastroenterology St Mark s Hospital Emerging Interventions in Endoscopy Margaret Vance Nurse Consultant in Gastroenterology St Mark s Hospital Colon Cancer Colon cancer is common. 1 in 20 people in the UK will develop the disease 19 000

More information

Colorectal Cancer Screening. Paul Berg MD

Colorectal Cancer Screening. Paul Berg MD Colorectal Cancer Screening Paul Berg MD What is clinical integration? AMA Definition The means to facilitate the coordination of patient care across conditions, providers, settings, and time in order

More information

Improving Access to Endoscopy at Safety-Net Hospitals. Lukejohn W. Day MD Assistant Professor of Medicine

Improving Access to Endoscopy at Safety-Net Hospitals. Lukejohn W. Day MD Assistant Professor of Medicine Improving Access to Endoscopy at Safety-Net Hospitals Lukejohn W. Day MD Assistant Professor of Medicine Goals Background Improving Access to Endoscopic Care Electronic referral: ereferral Direct Access

More information

Health Professional Information

Health Professional Information Bowel Screening Wales Health Professional Information 2011 www.bowelscreeningwales.org.uk Version 2.0 Acknowledgements Bowel Screening Wales would like to express their sincere thanks to the English and

More information

SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE

SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE The Condition 1. The condition should be an important health problem Colorectal

More information

IARC Handbook Volume 17: Colorectal Cancer Screening. Béatrice Lauby-Secretan, PhD on behalf of the IARC Working Group for Volume 17

IARC Handbook Volume 17: Colorectal Cancer Screening. Béatrice Lauby-Secretan, PhD on behalf of the IARC Working Group for Volume 17 IARC Handbook Volume 17: Colorectal Cancer Screening Béatrice Lauby-Secretan, PhD on behalf of the IARC Working Group for Volume 17 IARC Handbooks of Cancer Prevention An important part of cancer prevention

More information

The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?

The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? Robert A. Smith, PhD Cancer Control, Department of Prevention and Early Detection American Cancer Society

More information

Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M

Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion

More information

Why FIT (Faecal Immunochemical Test) is the best biomarker for CRC screening

Why FIT (Faecal Immunochemical Test) is the best biomarker for CRC screening Why FIT (Faecal Immunochemical Test) is the best biomarker for CRC screening Prof. Stephen Halloran Royal Surrey County Hospital NHS Cancer Screening Programme University of Surrey gfobt Guaiacum Officinale

More information

Are you ready for the Colorectal Cancer Screening Pilot Programme?

Are you ready for the Colorectal Cancer Screening Pilot Programme? Are you ready for the Colorectal Cancer Screening Pilot Programme? Dr Regina CHING Head, Surveillance and Epidemiology Branch Centre for Health Protection Department of Health 7 December 2014 Hong Kong

More information

Transition to Fecal Immunochemical Testing (FIT)

Transition to Fecal Immunochemical Testing (FIT) Transition to Fecal Immunochemical Testing (FIT) Frequently Asked Questions for Primary Care Providers October 2017 Version 1.1 Overview Ontario will be transitioning from the guaiac fecal occult blood

More information

NATIONAL SCREENING COMMITTEE

NATIONAL SCREENING COMMITTEE Optimising Bowel Cancer Screening Phase 1: Optimising the cost effectiveness of repeated FIT screening and screening strategies combining bowel scope and FIT screening Sophie Whyte, Chloe Thomas, Ben Kearns,

More information

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015 WEO CRC SC Meeting Barcelona, Spain October 23, 2015 THE HEMOGLOBIN CONCENTRATION IN A NEGATIVE RESULT AS A PREDICTOR FOR ADVANCED NEOPLASIA Isabel Portillo, Eunare Arana-Arri, Isabel Idigoras, Lorea Martínez-Indart.

More information

Colorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers

Colorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers Colorectal Cancer Screening in Ohio CHCs Ohio Association of Community Health Centers 2 1/29/2015 Your Speakers Dr. Ted Wymyslo Ashley Ballard Randy Runyon 3 1/29/2015 Facts 3 rd most common cancer in

More information

The burden of Colorectal Cancer in Asia. Dr Saunthari Somasundaram

The burden of Colorectal Cancer in Asia. Dr Saunthari Somasundaram q The burden of Colorectal Cancer in Asia Dr Saunthari Somasundaram Globocan 2018: Colon Cancer Tomorrow (Incidence) Global Patterns and Trends in Colorectal Cancer Incidence and Mortality Arnold M,Sierra

More information

National Bowel Screening Programme. Quick Guide

National Bowel Screening Programme. Quick Guide National Bowel Screening Programme Quick Guide What is the National Bowel Screening Programme? This is a free programme to help detect bowel cancer. The National Bowel Screening Programme is being rolled

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Holme Ø, Løberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. doi:10.1001/jama.2014.8266

More information

ENGAGING PRIMARY CARE IN BOWEL SCREENING

ENGAGING PRIMARY CARE IN BOWEL SCREENING ENGAGING PRIMARY CARE IN BOWEL SCREENING GP GOOD PRACTICE GUIDE SCOTLAND VERSION ENGAGING PRIMARY CARE IN BOWEL SCREENING GP GOOD PRACTICE GUIDE SCOTLAND VERSION CONTENT 2 Background & information on the

More information

Transforming Cancer Services for London

Transforming Cancer Services for London Programme Director Paul Roche Status Draft Owner Laura Boyd Version 0.4 Author Jennifer Layburn Date 15/05/13 Transforming Cancer Services for London Best Practice Commissioning Pathway for the early detection

More information

Cologuard Screening for Colorectal Cancer

Cologuard Screening for Colorectal Cancer Pending Policies - Medicine Cologuard Screening for Colorectal Cancer Print Number: MED208.056 Effective Date: 08-15-2016 Coverage: I.Cologuard stool DNA testing may be considered medically necessary for

More information

HOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING. Using your toolkit to conduct an evaluation

HOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING. Using your toolkit to conduct an evaluation EVALUATION TOOLKIT HOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING Using your toolkit to conduct an evaluation Welcome Mary Doroshenk, MA Director National

More information

Risk scoring incorporating FIT in triage of symptomatic patients

Risk scoring incorporating FIT in triage of symptomatic patients Risk scoring incorporating FIT in triage of symptomatic patients Centre for Research into Cancer Prevention and Screening University of Dundee Scotland Possible conflicts of interest None Background Symptoms

More information

CANCER SCREENING. Er Chaozer Department of General Medicine, Tan Tock Seng Hospital

CANCER SCREENING. Er Chaozer Department of General Medicine, Tan Tock Seng Hospital CANCER SCREENING Er Chaozer Department of General Medicine, Tan Tock Seng Hospital Introduction Screening average risk patients Benefits and harms from screening Early cancer detection early treatment

More information

Programme Report Round One

Programme Report Round One Programme Report 2012-2015 Round One Contents Introduction from the Head of Screening, National Screening Service 2 Message from the Clinical Director, BowelScreen 4 Message from the Programme Manager,

More information

Efficacy, effectiveness, quality: sources of data

Efficacy, effectiveness, quality: sources of data Efficacy, effectiveness, quality: sources of data Ondřej MÁJEK Institute of Biostatistics and Analyses, Masaryk University Institute of Biostatistics and Analyses, Masaryk University, Brno Key Questions

More information

Cost-effectiveness analysis of a screening programme. Iris Lansdorp-Vogelaar, PhD Department of Public Health Erasmus MC, Rotterdam

Cost-effectiveness analysis of a screening programme. Iris Lansdorp-Vogelaar, PhD Department of Public Health Erasmus MC, Rotterdam Cost-effectiveness analysis of a screening programme Iris Lansdorp-Vogelaar, PhD Department of Public Health Erasmus MC, Rotterdam Criteria of Wilson and Jungner (Bull World Health Organ. 1968) Why cost-effectiveness

More information

Updates in Colorectal Cancer Screening & Prevention

Updates in Colorectal Cancer Screening & Prevention Updates in Colorectal Cancer Screening & Prevention Swati G. Patel, MD MS Assistant Professor of Medicine Division of Gastroenterology & Hepatology Gastrointestinal Cancer Risk and Prevention Clinic University

More information

Improving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)

Improving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC) Improving Outcomes in Colorectal Cancer: The Science of Screening Tennessee Primary Care Association October 23, 2014 Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancers Colorectal Cancer

More information

Prevention and management of cancer in primary care. Presentation + interactive discussion with DoHA 11am Wednesday November 7 th 2012

Prevention and management of cancer in primary care. Presentation + interactive discussion with DoHA 11am Wednesday November 7 th 2012 Prevention and management of cancer in primary care Presentation + interactive discussion with DoHA 11am Wednesday November 7 th 2012 David Weller University of Edinburgh Visiting Fellow, Australian Primary

More information

Colon Cancer Screening. A Provider Opinion Survey

Colon Cancer Screening. A Provider Opinion Survey Colon Cancer Screening A Provider Opinion Survey 1. Background Information What is colon cancer? Who needs to be screened? Colorectal Cancer» Presence of abnormal cells in the colon or rectum that divide

More information

Screening for Colorectal Cancer

Screening for Colorectal Cancer Screening for Colorectal Cancer April 1, 2014 Revised August 2014 McMaster Evidence Review and Synthesis Centre Team: Donna Fitzpatrick-Lewis, Ali Usman, Rachel Warren, Meghan Kenny, Maureen Rice, Andy

More information

Practice Based Research at UC San Diego Family Medicine

Practice Based Research at UC San Diego Family Medicine Practice Based Research at UC San Diego Family Medicine William J. Sieber, Ph.D. and Gene A. Kallenberg, MD Workshop on Practice Based Research Dec. 5, 2015 Research Projects Goal: Describe several examples

More information

05/07/2018. Organisation. The English screening programme what is happening? Organisation. Bowel cancer screening in the UK is:

05/07/2018. Organisation. The English screening programme what is happening? Organisation. Bowel cancer screening in the UK is: Organisation The English screening programme what is happening? Phil Quirke Lead Pathologist Bowel Cancer Screening PHE England Bowel Cancer Screening Pathology Committee Started 2006 with roll out 4 devolved

More information

TPMG experience in improving colorectal cancer screening rates

TPMG experience in improving colorectal cancer screening rates TPMG experience in improving colorectal cancer screening rates Theodore R. Levin, MD Clinical Lead for CRC screening, The Permanente Medical Group, Inc Kaiser Permanente Northern California Kaiser Permanente

More information

ColonCancerCheck (CCC): Modelling FOBT screening in Ontario for colorectal cancer (CRC) using the Cancer Risk Management Model (CRMM)

ColonCancerCheck (CCC): Modelling FOBT screening in Ontario for colorectal cancer (CRC) using the Cancer Risk Management Model (CRMM) ColonCancerCheck (CCC): Modelling FOBT screening in Ontario for colorectal cancer (CRC) using the Cancer Risk Management Model (CRMM) CADTH Panel Presentation April 16, 2012 Toronto Health Economics and

More information

UK Bowel Cancer screening Dr Voi Shim Wong BsC MD FRCP. Consultant Gastroenterologist Accredited BCSP colonoscopist Whittington + UCL Hospitals

UK Bowel Cancer screening Dr Voi Shim Wong BsC MD FRCP. Consultant Gastroenterologist Accredited BCSP colonoscopist Whittington + UCL Hospitals UK Bowel Cancer screening 2017 Dr Voi Shim Wong BsC MD FRCP Consultant Gastroenterologist Accredited BCSP colonoscopist Whittington + UCL Hospitals Bowel Cancer Contents UK Bowel Cancer Screening Programme

More information

Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography

Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography 2019 Released 2019 health.govt.nz Citation: Ministry of Health. 2019. Referral Criteria for Direct Access

More information